Cytek Biosciences Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +60.4% | +37.8% | +28.2% | +17.7% | +3.9% | +0.5% | |
| – | +40.8% | +18.7% | +29.2% | +32.6% | +6.9% | +8.6% | |
| – | +80.3% | +53.1% | +27.6% | +8.4% | +1.5% | -6.0% | |
| – | +53.3% | +78.5% | +42.6% | +26.7% | -10.8% | -7.4% | |
| – | +39.0% | +122.4% | +66.5% | +26.8% | -2.0% | +36.7% | |
| – | -17.2% | +83.9% | +46.9% | +33.6% | -4.1% | +10.0% | |
| – | – | -33.0% | -119.7% | – | – | – | |
| – | +33,200.0% | +422.8% | +47.8% | -19.5% | +153.0% | -91.0% | |
| – | – | -58.8% | -78.8% | -1,346.7% | – | – | |
| – | -1,034.5% | – | -142.0% | – | – | +11,368.1% | |
| – | – | -84.5% | -14.2% | -571.6% | – | – | |
| – | – | -41.9% | +6.4% | -146.4% | – | -463.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.